Akebia Therapeutics Inc (AKBA)

04:39 AM

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Update - MarketBeat

04:39 AM

04:25 AM

Citigroup Inc. Has $5.23 Million Position in Akebia Therapeutics, Inc. $AKBA - MarketBeat

04:25 AM

02:27 AM

Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference - The Globe and Mail

02:27 AM

Mar 03, 2026

Akebia Therapeutics CEO to speak at Miami Leerink 2026 healthcare forum - Stock Titan

Mar 03, 2026

Mar 02, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 02, 2026

Mar 01, 2026

AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction - Stocktwits

Mar 01, 2026

Feb 28, 2026

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA) - The Globe and Mail

Feb 28, 2026

Feb 28, 2026

Akebia Therapeutics (NASDAQ:AKBA) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat

Feb 28, 2026

Feb 28, 2026

Wall Street Zen Downgrades Akebia Therapeutics (NASDAQ:AKBA) to Hold - MarketBeat

Feb 28, 2026

Feb 28, 2026

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Potential 233% Upside in the Healthcare Sector - DirectorsTalk Interviews

Feb 28, 2026

Feb 27, 2026

Akebia Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 27, 2026

Feb 27, 2026

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026

Feb 26, 2026

Akebia Therapeutics Inc (AKBA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - GuruFocus

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics, Inc. posts full year 2025 financial results amid commercial and pipeline expansion - Traders Union

Feb 26, 2026

Feb 26, 2026

Key facts: Akebia Therapeutics reports 47% revenue rise; Phase 2 trials planned - TradingView

Feb 26, 2026

Feb 26, 2026

Akebia (AKBA) Q4 2025 Earnings Call Transcript - AOL.com

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics (NASDAQ:AKBA) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics Q4 2025 Earnings Call Insights - Intellectia AI

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

AKBA: Vafseo launch drove 50% revenue growth in 2025, with expanding adoption and robust cash reserves - TradingView

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics Inc (NASDAQ:AKBA) Reports Q4 Revenue Beat and 49% Annual Growth Amid Mixed Market Reaction - ChartMill

Feb 26, 2026

Feb 26, 2026

Akebia (AKBA) Reports Strong Q4 Revenue and Positive Outlook for Vafseo - GuruFocus

Feb 26, 2026

Feb 26, 2026

AKEBIA THERAPEUTICS ($AKBA) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics, Inc. Q4 Loss Decreases - Nasdaq

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics, Inc. SEC 10-K Report - TradingView

Feb 26, 2026

Feb 26, 2026

AKBA: Revenue surged 47% to $236.2M in 2025, with Vafseo launch and pipeline expansion offsetting Auryxia LoE - TradingView

Feb 26, 2026

Feb 26, 2026

[8-K] Akebia Therapeutics, Inc. Reports Material Event | AKBA SEC FilingForm 8-K - Stock Titan

Feb 26, 2026

Feb 26, 2026

AKBA: Strong 2025 revenue growth and improved margins set the stage for Vafseo-led expansion in 2026 - TradingView

Feb 26, 2026

Feb 26, 2026

Kidney drug firm Akebia lifts revenue 49% as Vafseo grows - Stock Titan

Feb 26, 2026

Feb 26, 2026

Analysts Conflicted on These Healthcare Names: Akebia Therapeutics (AKBA), Idexx Laboratories (IDXX) and Arvinas Holding Company (ARVN) - The Globe and Mail

Feb 26, 2026

Feb 26, 2026

Akebia Therapeutics Q4 2025 Earnings Call Transcript - MarketBeat

Feb 26, 2026

Feb 25, 2026

Uncovering Potential: Akebia Therapeutics's Earnings Preview - Benzinga

Feb 25, 2026

Feb 25, 2026

BTIG Research Has Lowered Expectations for Akebia Therapeutics (NASDAQ:AKBA) Stock Price - MarketBeat

Feb 25, 2026

Feb 25, 2026

Where Akebia Therapeutics Stands With Analysts - Benzinga

Feb 25, 2026

Feb 25, 2026

BTIG Maintains Buy Rating on AKBA, Lowers Price Target by 20% | - GuruFocus

Feb 25, 2026

Feb 24, 2026

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 24, 2026

Feb 21, 2026

Akebia Therapeutics, Inc. (AKBA): Investor Outlook Reveals 289.83% Potential Upside - DirectorsTalk Interviews

Feb 21, 2026

Feb 20, 2026

Akebia Therapeutics (AKBA) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 20, 2026

Feb 19, 2026

Piper Sandler Lowers Akebia Therapeutics (AKBA) PT to $4 as Firm Updates Estimates Following Year-End Reports - Yahoo Finance

Feb 19, 2026

Feb 19, 2026

Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights - The Globe and Mail

Feb 19, 2026

Feb 19, 2026

Akebia Therapeutics to Report Fourth Quarter and Full Year - GlobeNewswire

Feb 19, 2026

Feb 19, 2026

Akebia schedules Feb. 26 webcast on 2025 results, recent moves - Stock Titan

Feb 19, 2026

Feb 17, 2026

MSN Money - MSN

Feb 17, 2026

Feb 17, 2026

Quarterly Earnings: How strong is Akebia Therapeutics Inc. stock balance sheetJuly 2025 Closing Moves & Weekly Top Gainers Trade List - mfd.ru

Feb 17, 2026

Feb 14, 2026

Can Akebia Therapeutics Inc. (AX9) stock sustain margin levels2025 Winners & Losers & Community Consensus Trade Signals - mfd.ru

Feb 14, 2026

Feb 13, 2026

Is Akebia Therapeutics Inc. a stock for growth or value investorsJuly 2025 Trends & Weekly Watchlist for Consistent Profits - mfd.ru

Feb 13, 2026

Feb 13, 2026

STATE STREET CORP's Strategic Acquisition of Akebia Therapeutics Inc Shares - GuruFocus

Feb 13, 2026

Feb 13, 2026

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: A Potential 238% Upside in the Healthcare Sector - DirectorsTalk Interviews

Feb 13, 2026

Feb 12, 2026

Akebia slumps after Q4 earnings miss - MSN

Feb 12, 2026

Feb 12, 2026

Akebia Therapeutics at Guggenheim Summit: Aiming for Dialysis Market Leadership - Investing.com Canada

Feb 12, 2026

Feb 12, 2026

AKBA: VAFSEO and pipeline progress drive growth, with major clinical catalysts expected in the next year - TradingView

Feb 12, 2026

Feb 12, 2026

Akebia Therapeutics Spotlights VAFSEO Dialysis Push, TIW Dosing Plan and Rare Kidney Pipeline at Summit - MarketBeat

Feb 12, 2026

Feb 12, 2026

How sensitive is Akebia Therapeutics Inc. to inflation2025 Technical Patterns & Weekly Top Gainers Alerts - mfd.ru

Feb 12, 2026

Feb 11, 2026

Is Akebia Therapeutics Inc. (AX9) stock a top dividend aristocrat candidateTrend Reversal & High Accuracy Investment Entry Signals - mfd.ru

Feb 11, 2026

Feb 11, 2026

What downside risks could hit Akebia Therapeutics Inc. (AX9) stockMarket Activity Report & Growth Focused Stock Pick Reports - mfd.ru

Feb 11, 2026

Feb 10, 2026

Can Akebia Therapeutics Inc. weather a recession2025 Earnings Surprises & Daily Profit Maximizing Tips - mfd.ru

Feb 10, 2026

Feb 10, 2026

Loss Report: Can Akebia Therapeutics Inc weather a recessionAnalyst Downgrade & Entry Point Confirmation Alerts - baoquankhu1.vn

Feb 10, 2026